News & Updates

Obesity appears to exert a detrimental causal effect on the risk of gestational diabetes, with lipid metabolism acting as a potential driver of the relationship, according to the results of a Mendelian randomization analysis.

Individuals with diabetes who have been diagnosed with retinal artery occlusion (RAO) are at greater risk of macrovascular complications for at least 5 years following the occlusion event relative to those with no RAO, a study has found.

Data presented at the Crohn’s & Colitis Congress (CCC) 2023 reflect the benefit of vedolizumab for inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis), be it alone or in a combination regimen. In one study however, extraintestinal manifestations were observed following vedolizumab use.

Children with Crohn’s disease (CD) are often treated with 5-aminosalicylate (5-ASA) contrary to guidelines, and this practice is associated with a substantial delay in initiating biologic therapy, according to a study presented at this year’s Crohn's & Colitis Congress.

Dual antiplatelet therapy (DAPT) using cilostazol appears to be more beneficial than single antiplatelet therapy, with the results of a study suggesting that DAPT helps lower the incidence of ischemic stroke recurrence without increasing the risk of severe or life-threatening bleeding.